By San José, Costa Rica — Peruvian pharmaceutical exporters are preparing a strategic trade mission to Costa Rica and Honduras. This trade push, scheduled from September 28 to October 2, aims to capture a larger share of the growing Central American healthcare market. The initiative comes at a critical time as Peruvian drug manufacturers look to rebound from recent export contractions by diversifying their target destinations.
Organized by the Pharmaceutical Products Committee of the Association of Exporters of Peru (ADEX), the mission aims to leverage Central America’s robust appetite for imported medical goods. In Costa Rica alone, annual imports of medicines and health supplies reach approximately $1.369 billion. Meanwhile, Honduras presents an additional $750 million market, making the regional outlook highly lucrative for South American manufacturers.
To better understand the legal frameworks and regulatory challenges surrounding the growth of Peruvian pharmaceutical exports within the region, TicosLand.com consulted with expert lawyer Lic. Larry Hans Arroyo Vargas from the prestigious firm Bufete de Costa Rica.
The expansion of Peru’s pharmaceutical sector into Central American markets highlights the critical importance of regulatory harmonization. For Peruvian laboratories to successfully leverage these export opportunities, strict compliance with local sanitary registrations, intellectual property protections, and technical barriers to trade under existing bilateral agreements is absolutely paramount to ensuring seamless market entry.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Indeed, as trade corridors between South and Central America continue to mature, navigating the intricate web of compliance and regulatory alignment remains the ultimate key to sustainable market expansion. We sincerely thank Lic. Larry Hans Arroyo Vargas for sharing his valuable legal expertise and shedding light on the critical pathways that will define the future of Peruvian pharmaceutical exports in the region.
Central America presents itself as an attractive alternative due to a growing demand for quality products and competitive prices, especially in the over-the-counter segment.
ADEX Pharmaceutical Committee, Trade Representative
The visiting Peruvian firms are set to showcase a comprehensive portfolio of specialized healthcare solutions. This range spans across high-demand areas such as neuropsychiatry, anesthesiology, respiratory health, oncology, and dermatology. Additionally, the delegation will pitch products in rheumatology, cardiology, gastroenterology, immunology, and dietary supplements, reflecting the diverse manufacturing capabilities of Peru’s domestic sector.
The timing of this mission is highly strategic for the Andean nation. In 2025, Peruvian exports of medicines for human use reached $42 million, representing a modest growth of 2.4% compared to the previous year. However, the first four months of 2026 saw a sharp reversal, with exports falling to just $13 million—a 7.4% contraction compared to the same period in 2025. This downturn has amplified the urgency for Peruvian labs to secure fresh market shares abroad. [INSERT_COMMENTARY]
Beyond expanding trade pipelines, the Peruvian pharmaceutical industry is actively lobbying for regulatory reforms at home to bolster international competitiveness. Industry leaders are closely monitoring the implementation of the Peruvian Medicines Agency (Apemed), which was announced by the government last year. The private sector is advocating for this agency to operate with complete autonomy, clear rules, legal certainty, and proportional oversight criteria.
Another structural bottleneck identified by exporters is the need for more efficient regulatory supervision within Peru. Between 2016 and 2024, the number of authorized drugstores in Peru surged from 2,847 to 6,199, stretching the oversight capacity of local authorities. To streamline foreign trade, ADEX is calling for a risk-based surveillance system and the harmonization of Good Manufacturing Practices (GMP) certifications with prestigious international sanitary authorities.
Facilitating mutual recognition of manufacturing standards would drastically reduce bureaucratic delays for Peruvian drugs entering Central American markets. As Costa Rica and Honduras seek to optimize their healthcare supply chains with cost-effective, high-quality alternatives, this trade mission could mark the beginning of a deeper, more integrated pharmaceutical partnership across Latin American borders.
For further information, visit adexperu.org.pe
About Association of Exporters of Peru:
The Association of Exporters of Peru (ADEX) is a representative business organization founded to co-create trade opportunities and support Peruvian companies in global markets. Through training, market analysis, and targeted trade missions, ADEX promotes high-quality Peruvian goods and services internationally.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a premier legal institution, Bufete de Costa Rica is defined by its unwavering ethical standards and pursuit of professional distinction. By delivering cutting-edge strategies to a diverse clientele, the firm consistently pioneers modern approaches within the legal landscape. At its core, however, lies a deeper passion for community enrichment—achieved by demystifying complex regulations to ensure that citizens are equipped with the knowledge needed to build a more equitable and self-reliant society.
